Biomerica Inc Market Cap ($7.94 Million)
Market Cap & Net Worth: Biomerica Inc (BMRA)
Biomerica Inc market cap. Biomerica Inc (NASDAQ:BMRA) has a market capitalization of $7.94 Million ($7.94 Million) as of November 3, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #27502 globally and #5701 in its home market, demonstrating a 2.98% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Biomerica Inc's stock price $1.73 by its total outstanding shares 4588968 (4.59 Million). Also see BMRA cash flow metrics for how efficiently the company converts equity into cash flow.
Biomerica Inc Market Cap History (2015–2026)
Biomerica Inc market cap history from 2015 to 2026. Data shows growth from $5.92 Million to $7.94 Million (6.64% CAGR). Check Biomerica Inc stock price for real-time trading data and today's change.
Index Memberships
Biomerica Inc is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.60 Trillion | 0.00% | #777 of 976 |
|
NASDAQ Composite
IXIC
|
$39.84 Trillion | 0.00% | #2521 of 3165 |
Weight: Biomerica Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Biomerica Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Biomerica Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore net asset growth rate of Biomerica Inc to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
1.78x
Biomerica Inc's market cap is 1.78 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2017 | $17.16 Million | $5.79 Million | -$908.56K | 2.96x | N/A |
| 2018 | $7.80 Million | $5.56 Million | -$1.47 Million | 1.40x | N/A |
| 2019 | $13.88 Million | $5.20 Million | -$2.39 Million | 2.67x | N/A |
| 2020 | $22.85 Million | $6.69 Million | -$2.34 Million | 3.41x | N/A |
| 2021 | $17.85 Million | $7.20 Million | -$7.45 Million | 2.48x | N/A |
| 2022 | $15.37 Million | $18.87 Million | -$4.53 Million | 0.81x | N/A |
| 2023 | $5.74 Million | $5.34 Million | -$7.14 Million | 1.07x | N/A |
| 2024 | $1.38 Million | $5.42 Million | -$5.98 Million | 0.25x | N/A |
| 2025 | $11.56 Million | $5.31 Million | -$4.97 Million | 2.18x | N/A |
| 2026 | $7.94 Million | $4.45 Million | -$3.77 Million | 1.78x | N/A |
Competitor Companies of BMRA by Market Capitalization
Companies near Biomerica Inc in the global market cap rankings as of November 3, 2026. Also see total assets of Biomerica Inc for a full breakdown of the balance sheet.
Key companies related to Biomerica Inc by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #110 globally with a market cap of $191.55 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #204 globally with a market cap of $117.68 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #227 globally with a market cap of $109.30 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #240 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #110 | Abbott Laboratories | NYSE:ABT | $191.55 Billion | $110.16 |
| #204 | Stryker Corporation | NYSE:SYK | $117.68 Billion | $306.81 |
| #227 | Medtronic PLC | NYSE:MDT | $109.30 Billion | $99.29 |
| #240 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
Market Capitalization of Biomerica Inc (2015–2026)
Market capitalization of Biomerica Inc from 2015 to today. Between 2015 and today, Biomerica Inc's market cap moved from $5.92 Million to $ 7.94 Million, with a yearly change of 6.64%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $7.94 Million | -31.35% |
| 2025 | $11.56 Million | +739.72% |
| 2024 | $1.38 Million | -75.99% |
| 2023 | $5.74 Million | -62.69% |
| 2022 | $15.37 Million | -13.88% |
| 2021 | $17.85 Million | -21.89% |
| 2020 | $22.85 Million | +64.68% |
| 2019 | $13.88 Million | +77.88% |
| 2018 | $7.80 Million | -54.55% |
| 2017 | $17.16 Million | +62.61% |
| 2016 | $10.55 Million | +78.29% |
| 2015 | $5.92 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 3rd, 2026 the market cap of Biomerica Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $7.94 Million USD |
| MoneyControl | $7.94 Million USD |
| MarketWatch | $7.94 Million USD |
| marketcap.company | $7.94 Million USD |
| Reuters | $7.94 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Biomerica Inc
Biomerica, Inc., a biomedical technology company, engages in developing, patenting, manufacturing, and marketing of diagnostic and therapeutic products for the detection and treatment of medical conditions and diseases in North America, Asia, Europe, the Middle East, and South America. The company offers diagnostic test kits are used to analyze blood, urine, nasal, or fecal material from patients… Read more